An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Sally Suliman
Sponsor
United Therapeutics Corporation
Unit
COM Phx Internal Medicine